ID: ALA4161983

Max Phase: Preclinical

Molecular Formula: C9H14O3

Molecular Weight: 170.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@@H](CC1CCC1)[C@@H]1CO1

Standard InChI:  InChI=1S/C9H14O3/c10-9(11)7(8-5-12-8)4-6-2-1-3-6/h6-8H,1-5H2,(H,10,11)/t7-,8-/m0/s1

Standard InChI Key:  FEOSGSOGAMPQLI-YUMQZZPRSA-N

Associated Targets(non-human)

Carboxypeptidase A1 174 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 170.21Molecular Weight (Monoisotopic): 170.0943AlogP: 1.28#Rotatable Bonds: 4
Polar Surface Area: 49.83Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.45CX Basic pKa: CX LogP: 1.43CX LogD: -1.42
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.65Np Likeness Score: 1.37

References

1. Testero SA, Granados C, Fernández D, Gallego P, Covaleda G, Reverter D, Vendrell J, Avilés FX, Pallarès I, Mobashery S..  (2017)  Discovery of Mechanism-Based Inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.,  (10): [PMID:29057062] [10.1021/acsmedchemlett.7b00346]

Source